Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117341) titled 'Median effective dose of oliceridine combined with propofol for analgesia in elderly patients undergoing prostate biopsy' on Jan. 22.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Affiliated Hospital of Jiangnan University
Condition:
Elevated PSA
Intervention:
Group E:The dose of oliceridine for each patient was determined using a modified Dixon sequential method
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-02-02
Target Sample Size: Group E:30;Group M:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showpro...